학술논문

Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013–14
Document Type
article
Source
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Sciences
Pneumonia & Influenza
Prevention
Biodefense
Emerging Infectious Diseases
Infectious Diseases
Vaccine Related
Influenza
2.2 Factors relating to the physical environment
Aetiology
Infection
Good Health and Well Being
Adolescent
Adult
Aged
Bacterial Infections
Child
Child
Preschool
Coinfection
Critical Care
Female
Humans
Incidence
Infant
Infant
Newborn
Influenza
Human
Male
Middle Aged
Retrospective Studies
Staphylococcal Infections
Survival Analysis
Virus Diseases
Young Adult
Severe influenza
Influenza A (H1N1) pdm09
Co-infection
Staphylococcus aureus
MRSA
ICU
Microbiology
Virology
Clinical sciences
Medical microbiology
Language
Abstract
BackgroundInfluenza acts synergistically with bacterial co-pathogens. Few studies have described co-infection in a large cohort with severe influenza infection.ObjectivesTo describe the spectrum and clinical impact of co-infections.Study designRetrospective cohort study of patients with severe influenza infection from September 2013 through April 2014 in intensive care units at 33 U.S. hospitals comparing characteristics of cases with and without co-infection in bivariable and multivariable analysis.ResultsOf 507 adult and pediatric patients, 114 (22.5%) developed bacterial co-infection and 23 (4.5%) developed viral co-infection. Staphylococcus aureus was the most common cause of co-infection, isolated in 47 (9.3%) patients. Characteristics independently associated with the development of bacterial co-infection of adult patients in a logistic regression model included the absence of cardiovascular disease (OR 0.41 [0.23-0.73], p=0.003), leukocytosis (>11K/μl, OR 3.7 [2.2-6.2], p